Diana Ngole is a dedicated Manufacturing Associate II at City of Hope, where she plays a pivotal role in the advanced manufacturing of lentivirus for Phase I and Phase II CAR-T cell therapy clinical trials. With a Bachelor of Science degree in Biological Sciences from...
Diana Ngole is a dedicated Manufacturing Associate II at City of Hope, where she plays a pivotal role in the advanced manufacturing of lentivirus for Phase I and Phase II CAR-T cell therapy clinical trials. With a Bachelor of Science degree in Biological Sciences from the University of California, Santa Barbara, Diana has cultivated a strong foundation in critical thinking and problem-solving, which she applies daily in her research and manufacturing processes. Her expertise lies in utilizing adherent 293T cell cultures and third-generation transient transfection methods, which have proven successful in generating consistently high viral titers essential for effective CAR-T cell therapies.
In her current role, Diana is deeply involved in optimizing production protocols and ensuring the quality and consistency of viral vectors. Her hands-on experience with techniques such as gel electrophoresis, flow cytometry, and virus culture enables her to troubleshoot and refine processes effectively. Diana's proficiency in mouse handling and intravenous injection further enhances her contributions to preclinical studies, where she supports the translation of laboratory findings into viable therapeutic options.
Diana is particularly passionate about the intersection of science and biotechnology, and she is eager to explore career opportunities that allow her to leverage her skills in a meaningful way. Her organizational skills and attention to detail are invaluable assets in a fast-paced manufacturing environment, where precision is critical to the success of clinical trials. As she continues to grow in her role, Diana remains committed to advancing the field of cellular therapies and contributing to innovative solutions that address pressing clinical challenges.